MIRM
MIRM
NASDAQ · Biotechnology

Mirum Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$87.88
-1.55 (-1.73%)
As of Mar 24, 9:53 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -24.1% upside
Low Target $36.90
Average Target $66.73
High Target $76.87
Current Price $87.88
Current
$87.88
Target
$66.73
$36.90 $66.73 avg $76.87
Scenario Analysis
Bear Case
$36.90
-58.0%
Low target
Base Case
$66.73
-24.1%
Avg target
Bull Case
$76.87
+-12.5%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$109.28
-19.6% from high
52-Week Low
$36.88
+138.3% from low
50-Day SMA
$87.61
+0.3% vs SMA
200-Day SMA
$68.12
+29.0% vs SMA
RSI (14)
56.6
Neutral
Target vs 52W High
$66.73
-38.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%